Actelion Submits a New Drug Application to the FDA for Macitentan (Opsumit

Actelion submits a New Drug Application to the FDA for macitentan (Opsumit

Filed under: drug treatment news

ALLSCHWIL/BASEL, SWITZERLAND – 22 October 2012 – Actelion (SIX: ATLN) today announced that it has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) seeking approval for macitentan (Opsumit®) for the treatment …
Read more on Reuters

 

Faith Outreach

Filed under: drug treatment news

Faith Outreach has begun a drug and alcohol rehabilitation program at the church on Highway 41 in Okolona that realizes overcoming addiction requires long-term treatment, there can be set-backs and turning your life around takes a belief in something …
Read more on The Chickasaw Journal

 

Allentown Rescue Mission ends drug treatment

Filed under: drug treatment news

The Allentown Rescue Mission abruptly closed its substance abuse treatment program Friday, laying off three employees. The 112-year-old charity at 355 Hamilton St. has been going through a season of change. Earlier this year it reduced the …
Read more on Allentown Morning Call

 

More drug treatment news Resources

Photos of Actelion submits a New <b>Drug</b> Application to the FDA for macitentan (Opsumit <b>…</b>” title=”Photos of Actelion submits a New <b>Drug</b> Application to the FDA for macitentan (Opsumit <b>…</b>” /></a> </p>
<p style=News Actelion Submits NDA To FDA On Macitentan – Quick Facts
Actelion Submits NDA To FDA On Macitentan – Quick Facts … Read News

Actelion submits a New <b>Drug</b> Application to the FDA for macitentan (Opsumit <b>…</b> Pictures” title=”Actelion submits a New <b>Drug</b> Application to the FDA for macitentan (Opsumit <b>…</b> Pictures” /></a> </p>
<p style=News Actelion Submits A New Drug Application To The FDA For Macitentan (Opsumit) For The Treatment Of Patients With …
ALLSCHWIL/BASEL, SWITZERLAND – 22 October 2012 – Actelion (SIX: ATLN) today announced that it has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) seeking approval for … Read News